Sygnature Discovery is a leading independent provider of integrated drug discovery resources and expertise. As a Contract Research Organisation (CRO), it supports pharmaceutical companies in their quest to develop new therapeutics, offering a comprehensive suite of services that spans the entire drug discovery process. This enables clients to navigate the complexities of drug development with confidence, leveraging Sygnature Discovery's innovative approaches and experienced team.

Services include:
- Target validation
- Hit identification
- Hit to lead
- Lead optimization
- Integrated drug discovery
- Medicinal chemistry
- DMPK (Drug Metabolism and Pharmacokinetics)
- In vitro and in vivo pharmacology
- Structural biology

Sygnature Discovery is dedicated to advancing drug discovery efforts for the pharmaceutical industry, providing tailored solutions to meet the unique needs of each project. For more information, visit sygnaturediscovery.com.